procaterol has been researched along with Hemolysis in 1 studies
Procaterol: A long-acting beta-2-adrenergic receptor agonist.
Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, K | 1 |
| Shintani, S | 1 |
| Yamashita, S | 1 |
| Tei, S | 1 |
| Takai, M | 1 |
| Tsutsui, M | 1 |
| Kawamura, K | 1 |
| Ohkawa, T | 1 |
| Hiyama, T | 1 |
| Yabuuchi, Y | 1 |
1 other study available for procaterol and Hemolysis
| Article | Year |
|---|---|
[Pharmacological properties of procaterol, a newly synthesized, specific beta 2-adrenoceptor stimulant. Part II. Effects on the peripheral organs (author's transl)].
Topics: Adrenergic beta-Agonists; Anesthetics, Local; Animals; Autonomic Nervous System; Blood Coagulation; | 1979 |